IMMUTEP
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology. Their products include a T cell immunostimulatory factor (APC activator) for cancer chemo-immunotherapy and a therapeutic antibody for immune response modulation in cancer. The Company's technologies are based on the LAG-3 immune control mechanism which plays a vital role in the regulation of the T cell immune response.
IMMUTEP
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
1987-05-21
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.immutep.com
Total Employee:
11+
Status:
Active
Contact:
+33169289992
Total Funding:
19.05 M AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache Euro
Similar Organizations
Atlantic Healthcare
A rare disease pharmaceutical company acquiring, developing and commercializing therapeutics, specializing in gastroenterology.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
CF PharmTech
CF PharmTech is a specialty pharmaceutical company that develops and manufactures inhalation products.
Complix
Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Gmax Biopharm
Gmax Biopharm dvelope innovative GPCR Antibody therapeutics for unmet medical use.
HealthMatch
HealthMatch connects patients with revolutionary drugs and cures.
IceCure Medical Ltd.
IceCure is a medical device company setting new standards in minimally-invasive tumor therapy women’s health and interventional oncology.
Innocare
InnoCare is a Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases.
Oncopeptides
Oncopeptides AB is a privately held clinical stage company developing melflufen, a peptidase potentiated therapy for multiple myeloma.
OneOme
OneOme is a collaborative concern between the business builder .
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Promontory Therapeutics
Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.
Vaccinex
Vaccinex is a biotechnology company engaged in the development of novel therapeutic antibodies for neurodegenerative disorders and oncology.
Vesselon
Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Prescient Therapeutics
Prescient Therapeutics is a biopharmaceutical company, discovers and develops novel immunotherapeutic products for the treatment of chronic.
Current Employees Featured
Founder
Stock Details
Investors List
Australian Ethical Investment
Australian Ethical Investment investment in Post-IPO Equity - Immutep
Altium Capital
Altium Capital investment in Post-IPO Equity - Immutep
Platinum AM
Platinum AM investment in Post-IPO Equity - Immutep
Official Site Inspections
http://www.immutep.com Semrush global rank: 4.05 M Semrush visits lastest month: 3.02 K
- Host name: dd32834.kasserver.com
- IP address: 85.13.133.184
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
